Evidence map›Paper›PMID 23867321›Full record

ArticleTuberculosis (Edinburgh, Scotland)2013

pncA gene expression and prediction factors on pyrazinamide resistance in Mycobacterium tuberculosis.

Patricia Sheen, Katherine Lozano, Robert H Gilman, Hugo J Valencia, Sebastian Loli, Patricia Fuentes, Louis Grandjean, Mirko Zimic

Abstract read
In one paragraph

Article in Tuberculosis (Edinburgh, Scotland), 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 19 papers.

0numbers the graph read from it
0cells of the map it votes in
19citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

19 citing papers in PubMed.

  1. Article
  2. Article
  3. Pyrazinamide-resistant Tuberculosis Obscured From Common Targeted Molecular Diagnostics.Drug resistance updates : reviews and commentaries in antimicrobial and anticancer chemotherapy · 2023
    Article
  4. Detection of Mutations inCurrent issues in molecular biology · 2022
    Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Mycobacterium kansasii.Microbiology spectrum · 2017
    Review
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Patricia SheenUnidad de Bioinformática y Biología Molecular, Laboratorios de Investigación y Desarrollo, Facultad de Ciencias y Filosofía, Universidad Peruana Cayetano Heredia, Av. Honorio Delgado 430, SMP, Lima, Peru.
Katherine Lozano
Robert H Gilman
Hugo J Valencia
Sebastian Loli
Patricia Fuentes
Louis Grandjean
Mirko Zimic

Funding

Serological &Molecular Techniques-- Epidemiology of Cyclospora cayetanensisP01AI051976 · NIAID · UNIVERSIDAD PERUANA CAYETANO HEREDIA · PI GARCIA, HECTOR HUGO · 2002 to 2006
$3.3M
Infectious Diseases Training Program in PeruD43TW006581 · FIC · JOHNS HOPKINS UNIVERSITY · PI GILMAN, ROBERT H · 2003 to 2012
$2.4M
The effect of pncA expression and POA efflux rate in the level of PZA-resistanceR01TW008669 · FIC · UNIVERSIDAD PERUANA CAYETANO HEREDIA · PI ZIMIC, MIRKO · 2010 to 2010
$53k
FIC NIH HHS 1R01TW008669-01FIC NIH HHS 3 D43 TW006581FIC NIH HHS D43 TW006581FIC NIH HHS R01 TW008669Medical Research Council MR/K007467/1NIAID NIH HHS 1P01 AI51976NIAID NIH HHS P01 AI051976
6 · The paper itself

Abstract

Mutations in the pyrazinamidase (PZAse) coding gene, pncA, have been considered as the main cause of pyrazinamide (PZA) resistance in Mycobacterium tuberculosis. However, recent studies suggest there is no single mechanism of resistance to PZA. The pyrazinoic acid (POA) efflux rate is the basis of the PZA susceptibility Wayne test, and its quantitative measurement has been found to be a highly sensitive and specific predictor of PZA resistance. Based on biological considerations, the POA efflux rate is directly determined by the PZAse activity, the level of pncA expression, and the efficiency of the POA efflux pump system. This study analyzes the individual and the adjusted contribution of PZAse activity, pncA expression and POA efflux rate on PZA resistance. Thirty M. tuberculosis strains with known microbiological PZA susceptibility or resistance were analyzed. For each strain, PZAse was recombinantly produced and its enzymatic activity measured. The level of pncA mRNA was estimated by quantitative RT-PCR, and the POA efflux rate was determined. Mutations in the pncA promoter were detected by DNA sequencing. All factors were evaluated by multiple regression analysis to determine their adjusted effects on the level of PZA resistance. Low level of pncA expression associated to mutations in the pncA promoter region was observed in pncA wild type resistant strains. POA efflux rate was the best predictor after adjusting for the other factors, followed by PZAse activity. These results suggest that tests which rely on pncA mutations or PZAse activity are likely to be less predictive of real PZA resistance than tests which measure the rate of POA efflux. This should be further analyzed in light of the development of alternate assays to determine PZA resistance.

Indexed as

AmidohydrolasesAntitubercular AgentsDrug Resistance, BacterialGenes, BacterialHumansMicrobial Sensitivity TestsMutationMycobacterium tuberculosisPromoter Regions, GeneticPyrazinamideRNA, BacterialRNA, MessengerAmidohydrolasesAntitubercular AgentsPncA protein, Mycobacterium tuberculosisPyrazinamidepyrazinamide deamidasepyrazinoic acidRNA, BacterialRNA, MessengerMycobacterium tuberculosispncA expression levelPOA efflux ratePZA resistancePZAse activity

Identifiers

PMID23867321
PMCPMC3755357

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.